アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
Chromatin modifiers, non-coding RNAs and transcription factors are key modulators of gene expression during the development of the peripheral and central nervous systems. Their regulatory role in neural cell function and in neurological diseases has been emerging in recent years. This meeting will gather experts with key findings in the field of neuroepigenetics to discuss these latest developments, and novel technologies which currently allow the study of neural gene regulation mechanisms with an unprecedented detail and resolution.
Short talk and poster presentation places are available. Abstracts can be submitted during online registration.
before Feb 21
before Mar 28
before May 16
Registration fee includes:
Confirmation note: All registered attendees will receive an email confirmation from firstname.lastname@example.org within 48 hours of registering. If you do not receive this confirmation, please contact the Abcam Events Team to confirm your registration.
Start: June 8 2022, 3.00pm Finish: June 10 2022, 5.00pm
Note, these times are provisional and subject to change. A detailed program will be available closer to the time.
The MDC.C – Max Delbrück Communications Center is one of the most modern congress centers in Berlin. An international gathering place for scientific dialogue has been established in the center of the campus Berlin-Buch, which focus is on basic molecular research, clinical medicine and modern biotechnology.
Information on accommodation is available on the Berlin Tourism website.
* Important note *
Abcam does not have an affiliated hotel agency for this event. Please be careful of direct approaches from companies offering hotel reservations for this event. Reservations made by unaffiliated organizations may appear to be for lower rates, however they may be illegitimate, have unreasonable cancelation or change penalties, or be completely non-refundable. Please be aware of, and report any unauthorized solicitation to Abcam.
* Meeting image provided by Elisa Floriddia (Castelo-Branco Group, MBB/Molecular Neurobiology, Karolinska Institutet, Scheeles väg 2, 171 77 Stockholm, Sweden).